Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2B, Randomized, Controlled Study of HTX-011 Administered Via Pectoral Nerve Block in Subjects Undergoing Upper Extremity Surgery for Augmentation Mammoplasty

NCT03011333 is registered in ClinicalTrials.gov with Heron Therapeutics as lead sponsor.

NCT NCT03011333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03011333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2B, Randomized, Controlled Study of HTX-011 Administered Via Pectoral Nerve Block in Subjects Undergoing Upper Extremity Surgery for Augmentation Mammoplasty
Lead sponsor
Heron Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 14, 2017
Completion date
March 19, 2018
Enrollment
243 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain